RAMM Pharma Corp.
RAMM
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 63.81% | 89.16% | -1,254.79% | -160.93% | 79.72% |
| Total Depreciation and Amortization | -16.31% | 4.80% | -22.15% | -30.04% | -7.66% |
| Total Amortization of Deferred Charges | -20.00% | 25.00% | 0.00% | -- | -- |
| Total Other Non-Cash Items | 58.43% | -107.66% | 71,619.23% | 98.92% | -2,898.13% |
| Change in Net Operating Assets | -188.01% | -60.83% | 1,173.30% | -24.20% | -64.97% |
| Cash from Operations | -178.74% | -310.43% | 65.35% | 47.95% | -82.51% |
| Capital Expenditure | -- | -- | -- | -- | 200.00% |
| Sale of Property, Plant, and Equipment | -83.47% | 49.96% | 635.15% | -93.40% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -83.47% | 49.96% | 635.15% | -93.61% | 3,361.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.09% | -9.36% | -0.59% | 64.88% | 23.17% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 95.12% | -- | -- |
| Cash from Financing | 10.14% | -8.66% | 30.60% | 46.33% | 23.02% |
| Foreign Exchange rate Adjustments | 139.56% | -927.27% | 178.57% | 92.51% | -276.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -572.94% | -32.36% | 225.83% | -184.33% | 179.39% |